Stevanato Group (NYSE:STVN) Shares Up 1.5% – Should You Buy?

Stevanato Group S.p.A. (NYSE:STVN) shot up 1.5% on Wednesday . The company traded as high as €21.80 ($22.95) and last traded at €21.62 ($22.76). 37,826 shares were traded during mid-day trading, a decline of 92% from the average session volume of 500,026 shares. The stock had previously closed at €21.30 ($22.42).

Analysts Set New Price Targets

STVN has been the subject of several recent research reports. Wolfe Research started coverage on shares of Stevanato Group in a research note on Friday. They issued an “outperform” rating and a $28.00 price objective for the company. Bank of America upped their price target on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday. Finally, Morgan Stanley reissued an “equal weight” rating and set a $23.00 price objective (down from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Stevanato Group presently has an average rating of “Moderate Buy” and an average target price of €28.60 ($30.11).

Stevanato Group Trading Up 3.7 %

The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The company has a 50-day moving average price of €19.58 and a 200-day moving average price of €19.65.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The company’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.16 earnings per share. On average, equities analysts anticipate that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Hedge Funds Weigh In On Stevanato Group

A number of hedge funds have recently made changes to their positions in STVN. Conestoga Capital Advisors LLC raised its holdings in shares of Stevanato Group by 5.5% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 7,675,910 shares of the company’s stock valued at $153,518,000 after buying an additional 400,087 shares during the period. Thrivent Financial for Lutherans lifted its position in shares of Stevanato Group by 67.6% during the third quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock worth $55,698,000 after purchasing an additional 1,123,104 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Stevanato Group by 4.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock worth $53,872,000 after acquiring an additional 115,050 shares in the last quarter. Bamco Inc. NY boosted its holdings in Stevanato Group by 1.3% in the third quarter. Bamco Inc. NY now owns 1,685,181 shares of the company’s stock worth $33,704,000 after purchasing an additional 21,469 shares during the period. Finally, Fred Alger Management LLC grew its position in shares of Stevanato Group by 24.2% during the 3rd quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company’s stock valued at $21,411,000 after buying an additional 208,830 shares during the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.